Table 3

Comparisons of baseline and follow-up data between low and high MSGFR groups

Low MSGFR groupHigh MSGFR groupP value
Baseline
 Number of eyes108
 Age33 (24.5–40.5) years31.5 (24–43.75) years0.897
 Sex5 males, 5 females2 males, 6 females0.367
 Sides6 right eyes, 4 left eyes5 right eyes, 3 left eyes1.0
 Aetiology9 SJSs, 1 GVHDs6 SJSs, 2 GVHDs0.537
 Medical history15 (6–23) years5 (4.25–10.5) years0.101
 Donors sizes8 (6.49–11.41) cm2 8.13 (6.88–10.18) cm2 0.829
 Schirmer test0 (0–0) mm0 (0–2.75) mm0.315
 FL12 (9–12)12 (12–12)0.315
 TBUT0 (0–0) s0 (0–0) s1.0
 BCVA0.05 (0.01–0.45)0.09 (0.05–0.10)0.173
3 months follow-up
 Number of eyes108
 Schirmer test1 (0.5–4) mm5 (4–6) mm0.012
 FL10 (9–12)10 (8.5–10)0.315
 TBUT0 (0–0) s0 (0–0) s0.696
 BCVA0.02 (0.01–0.44)0.15 (0.06–0.4)0.068
Long-term follow-up
 Number of eyes9*8
 Follow-up time3 (3–4.5) years4.5 (2.25–6) years0.573
 Schirmer test1 (0–5) mm5 (4–7) mm0.027
 FL8 (8–12)10 (6.5–11.5)0.673
 TBUT0 (0–0)0 (0–0)1.0
 BCVA0.05 (0.01–0.43)0.19 (0.1–0.4)0.139
  • Continuous variables were shown as median (IQR).

  • *One eye was lost to follow-up after 3 months.

  • BCVA, best-corrected visual acuity; DED, dry eye disease; FL, corneal fluorescein staining score; GVHD, graft versus host disease; MSGFR, salivary flow rate of minor salivary glands; SJS, Stevens–Johnson syndrome; TBUT, value of break-up time of tear-film.